niacinamide has been researched along with Leishmania Infection in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " donovani in the BALB/c mouse model of infection; dosing on days 7-11 with a 50 mg/kg oral dose of sunitinib, lapatinib or sorafenib reduced liver amastigote burdens by 41%, 36% and 30%, respectively, compared with untreated control mice." | 1.40 | Activity of anti-cancer protein kinase inhibitors against Leishmania spp. ( Croft, SL; Sanderson, L; Yardley, V, 2014) |
| " Drug combination studies, performed on L." | 1.37 | In vitro activity of nicotinamide/antileishmanial drug combinations. ( Ait-Oudhia, K; Garcia, D; Gazanion, E; Ouaissi, A; Oury, B; Sereno, D; Seveno, M; Vergnes, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanderson, L | 1 |
| Yardley, V | 1 |
| Croft, SL | 1 |
| Gazanion, E | 1 |
| Vergnes, B | 1 |
| Seveno, M | 1 |
| Garcia, D | 1 |
| Oury, B | 1 |
| Ait-Oudhia, K | 1 |
| Ouaissi, A | 1 |
| Sereno, D | 1 |
2 other studies available for niacinamide and Leishmania Infection
| Article | Year |
|---|---|
Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Disease Models, Animal; Drug Repositioning; In | 2014 |
In vitro activity of nicotinamide/antileishmanial drug combinations.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Cell Line; DNA Fragmentation; Drug Combinations; Dru | 2011 |